On October 25, 2025, Albemarle Corp announced a deal to sell part of Ketjen Corp for approximately $800 million and expects to receive around $660 million from this sale and another deal by mid-2026. This transaction includes a non-cash goodwill impairment charge of $181.5 million expected in Q3 2025, reflecting the revaluation of assets as of September 30, 2025.